Adam Odolil1, Amy E Wright1, Lynsey M Keator1, Shannon M Sheppard1, Bonnie Breining1, Donna C Tippett1,2,3, Argye E Hillis1,2,4. 1. Department of Neurology, Johns Hopkins University School of Medicine. 2. Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine. 3. Department of Otolaryngology & Head & Neck Surgery, Johns Hopkins University School of Medicine. 4. Department of Cognitive Science, Johns Hopkins University.
Abstract
BACKGROUND: The rate of decline in language in Primary Progressive Aphasia (PPA) is highly variable and difficult to predict at baseline. The severity of diffuse white matter disease (leukoaraiosis), a marker of overall brain health, may substantially influence the rate of decline. AIMS: To test the hypothesis that leukoaraiosis is associated with a steeper decline in naming in PPA. METHODS AND PROCEDURES: In this longitudinal, observational study, 29 individuals with PPA (all variants) were administered the Boston Naming Test (BNT) at baseline and 1 year later. Two raters evaluated leukoaraiosis on baseline MRI, using the Cardiovascular Health Study scale. We evaluated the effects of leukoaraiosis severity, age, education, and baseline BNT on decline measured by change in BNT accuracy with multivariable linear regression. We also evaluated the effects of these variables on the dichotomized outcome of faster decline in BNT (worst 50%) versus slower decline (best 50%) using logistic regression. RESULTS: Together, leukoaraiosis, age, education, and baseline BNT score predicted change in BNT score (F(3, 25) = 8.12; p=0.0006). Change in BNT score was predicted by severity of leukoaraiosis (t =-3.81; p=0.001) and education (t= -2.45; p=0.022), independently of the other variables. When we dichotomized outcome into upper 50th percentile versus lower 50th percentile (faster decline), faster decline was predicted by all variables together (chi squared = 13.91; p = 0.008). However, only leukoaraiosis independently predicted outcome (OR=2.80; 95%CI: 1.11 to 7.03). For every 1 point increase on the CHS rating scale, there was 2.8 times higher chance of showing faster decline in naming. CONCLUSION: Severity of leukoaraiosis is associated with steeper decline in naming in PPA. This imaging marker can aide in prognosis and planning by caregivers and stratification of participants in clinical trials.
BACKGROUND: The rate of decline in language in Primary Progressive Aphasia (PPA) is highly variable and difficult to predict at baseline. The severity of diffuse white matter disease (leukoaraiosis), a marker of overall brain health, may substantially influence the rate of decline. AIMS: To test the hypothesis that leukoaraiosis is associated with a steeper decline in naming in PPA. METHODS AND PROCEDURES: In this longitudinal, observational study, 29 individuals with PPA (all variants) were administered the Boston Naming Test (BNT) at baseline and 1 year later. Two raters evaluated leukoaraiosis on baseline MRI, using the Cardiovascular Health Study scale. We evaluated the effects of leukoaraiosis severity, age, education, and baseline BNT on decline measured by change in BNT accuracy with multivariable linear regression. We also evaluated the effects of these variables on the dichotomized outcome of faster decline in BNT (worst 50%) versus slower decline (best 50%) using logistic regression. RESULTS: Together, leukoaraiosis, age, education, and baseline BNT score predicted change in BNT score (F(3, 25) = 8.12; p=0.0006). Change in BNT score was predicted by severity of leukoaraiosis (t =-3.81; p=0.001) and education (t= -2.45; p=0.022), independently of the other variables. When we dichotomized outcome into upper 50th percentile versus lower 50th percentile (faster decline), faster decline was predicted by all variables together (chi squared = 13.91; p = 0.008). However, only leukoaraiosis independently predicted outcome (OR=2.80; 95%CI: 1.11 to 7.03). For every 1 point increase on the CHS rating scale, there was 2.8 times higher chance of showing faster decline in naming. CONCLUSION: Severity of leukoaraiosis is associated with steeper decline in naming in PPA. This imaging marker can aide in prognosis and planning by caregivers and stratification of participants in clinical trials.
Entities:
Keywords:
leukoaraiosis; primary progressive aphasia; prognosis; white matter disease
Authors: M Cotelli; B Borroni; R Manenti; A Alberici; M Calabria; C Agosti; A Arévalo; V Ginex; P Ortelli; G Binetti; O Zanetti; A Padovani; S F Cappa Journal: Neuropsychology Date: 2006-09 Impact factor: 3.295
Authors: Graeme C Schwindt; Naida L Graham; Elizabeth Rochon; David F Tang-Wai; Nancy J Lobaugh; Tiffany W Chow; Sandra E Black Journal: Hum Brain Mapp Date: 2011-11-23 Impact factor: 5.038
Authors: Maria Luisa Mandelli; Eduardo Caverzasi; Richard J Binney; Maya L Henry; Iryna Lobach; Nikolas Block; Bagrat Amirbekian; Nina Dronkers; Bruce L Miller; Roland G Henry; Maria Luisa Gorno-Tempini Journal: J Neurosci Date: 2014-07-16 Impact factor: 6.167
Authors: Stéphanie Debette; Alexa Beiser; Charles DeCarli; Rhoda Au; Jayandra J Himali; Margaret Kelly-Hayes; Jose R Romero; Carlos S Kase; Philip A Wolf; Sudha Seshadri Journal: Stroke Date: 2010-02-18 Impact factor: 7.914
Authors: Rajani Sebastian; Carol B Thompson; Nae-Yuh Wang; Amy Wright; Aaron Meyer; Rhonda B Friedman; Argye E Hillis; Donna C Tippett Journal: Aphasiology Date: 2018-06-28 Impact factor: 2.773
Authors: Ajay Madhavan; Christopher G Schwarz; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Daniel A Drubach; Kejal Kantarci; Scott A Przybelski; Robert I Reid; Matthew L Senjem; Jeffrey L Gunter; Liana G Apostolova; Val J Lowe; Ronald C Petersen; Clifford R Jack; Keith A Josephs; Jennifer L Whitwell Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Bonnie L Breining; Andreia V Faria; Brian Caffo; Erin L Meier; Shannon M Sheppard; Rajani Sebastian; Donna C Tippett; Argye E Hillis Journal: Aphasiology Date: 2021-05-11 Impact factor: 1.902